ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$25.29
-1.14 (-4.31%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+239.2% upside
Low Target
$74.20
Average Target
$85.78
High Target
$112.10
Current Price
$25.29
Current
$25.29
$25.29
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Scenario Analysis
Bear Case
$74.20
193.4%
Low target
Base Case
$85.78
+239.2%
Avg target
Bull Case
$112.10
+343.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$31.77
-20.4% from high
52-Week Low
$13.70
+84.7% from low
50-Day SMA
$27.64
-8.5% vs SMA
200-Day SMA
$20.38
+24.1% vs SMA
RSI (14)
67.5
Neutral
Target vs 52W High
$85.78
+170.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |